| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A benefit-risk Model to Facilitate DMC-sponsor Communication and Decision Making
|
Sashegyi, Andreas
|
|
|
|
6 |
p. 749-757
|
artikel
|
| 2 |
Accounting for Interim Analyses in the Assessment of Program Expected Net Present Value
|
Kaiser, Lee
|
|
|
|
6 |
p. 597-606
|
artikel
|
| 3 |
A Comparative Study of the Communication of Drug Safety Information by Governmental Agencies in Japan and Western Countries: The Case of Asthma Medications
|
Yamamoto, Michiko
|
|
|
|
6 |
p. 583-596
|
artikel
|
| 4 |
A Contract Research Organization's Challenge: Validating Cutting-Edge Software for Imaging in Clinical Studies
|
Young, Brenda K.
|
|
|
|
6 |
p. 719-725
|
artikel
|
| 5 |
Adverse Reaction Signaling and Disproportionality Analysis: An Update
|
Faich, Gerald
|
|
2012
|
|
6 |
p. 708-714
|
artikel
|
| 6 |
Adverse Reaction Signaling and Disproportionality Analysis: An Update
|
Faich, Gerald
|
|
|
|
6 |
p. 708-714
|
artikel
|
| 7 |
A Longitudinal Model and Graphic for Beneft-risk Analysis, With Case Study
|
Norton, Jonathan D.
|
|
|
|
6 |
p. 741-747
|
artikel
|
| 8 |
A Matrix to Determine Health Economic Viability Throughout Product Development: A Pharmaceutical Industry Perspective
|
Hemels, Michiel
|
|
|
|
6 |
p. 749-756
|
artikel
|
| 9 |
Analysis of Questionnaire Data concerning Bar Codes Printed on Ampoule Labels
|
Kimura, Masaomi
|
|
|
|
6 |
p. 693-701
|
artikel
|
| 10 |
An Approach to Integrated Safety Analyses from Clinical Studies
|
Rosenkranz, Gerd K.
|
|
|
|
6 |
p. 649-657
|
artikel
|
| 11 |
An Investigation of Proportion Designs Based on a Molecularly Targeted Endpoint
|
Kong, Seung-Ho
|
|
|
|
6 |
p. 527-535
|
artikel
|
| 12 |
A Noninferiority Margin for Acne Lesion Counts
|
Gerlinger, Christoph
|
|
|
|
6 |
p. 607-615
|
artikel
|
| 13 |
A Note on Stratification in Clinical Trials
|
Permutt, Thomas
|
|
|
|
6 |
p. 719-722
|
artikel
|
| 14 |
Application of the Benefit-Risk Action Team (BRAT) Framework in Pharmaceutical R&D: Results From a Pilot Program
|
Noel, Rebecca
|
|
2012
|
|
6 |
p. 736-743
|
artikel
|
| 15 |
Application of the Benefit-Risk Action Team (BRAT) Framework in Pharmaceutical R&D: Results From a Pilot Program
|
Noel, Rebecca
|
|
|
|
6 |
p. 736-743
|
artikel
|
| 16 |
A Practical Approach to Evidence-Based Medicine for the Medical Communications Professional
|
Bryant, Patrick J.
|
|
|
|
6 |
p. 663-672
|
artikel
|
| 17 |
Are Pharmaceutical Market Withdrawals Preventable? A Preliminary Analysis
|
Daggumalli, Jaya Sai V.
|
|
2012
|
|
6 |
p. 694-700
|
artikel
|
| 18 |
Are Pharmaceutical Market Withdrawals Preventable? A Preliminary Analysis
|
Daggumalli, Jaya Sai V.
|
|
|
|
6 |
p. 694-700
|
artikel
|
| 19 |
A Review of Methods and Applications of the ROC Curve in Clinical Trials
|
Kumar, Ramesh V
|
|
|
|
6 |
p. 659-671
|
artikel
|
| 20 |
A Review of Pharmacoepidemiology and Therapeutic Risk Management
|
Hoff, Steven F.
|
|
|
|
6 |
p. 635-636
|
artikel
|
| 21 |
Assessment of Electronic Drug Information Resource Availability in Alabama Pharmacies
|
Hughes, Peter J.
|
|
|
|
6 |
p. 797-803
|
artikel
|
| 22 |
Associate Editor’s Commentary: In Praise of a BRAT
|
Pitts, Peter J.
|
|
2012
|
|
6 |
p. 645-646
|
artikel
|
| 23 |
Associate Editor’s Commentary: In Praise of a BRAT
|
Pitts, Peter J.
|
|
|
|
6 |
p. 645-646
|
artikel
|
| 24 |
Associate Editor’s Commentary: The Danger of Shorting Drug Shortages
|
Pitts, Peter J.
|
|
|
|
6 |
p. 697-698
|
artikel
|
| 25 |
A Statistical Framework for Decision Making in Confirmatory Multipopulation Tailoring Clinical Trials
|
Millen, Brian A.
|
|
2012
|
|
6 |
p. 647-656
|
artikel
|
| 26 |
A Statistical Framework for Decision Making in Confirmatory Multipopulation Tailoring Clinical Trials
|
Millen, Brian A.
|
|
|
|
6 |
p. 647-656
|
artikel
|
| 27 |
Auditing Medical Information Services Across Western Europe: A Cost-Effective Approach
|
Wormleighton, Charlotte
|
|
|
|
6 |
p. 655-662
|
artikel
|
| 28 |
Behavioral Intentions and Information-Seeking Behavior: A Comparison of Nonbranded versus Branded Direct-to-Consumer Prescription Advertisements
|
Rollins, Brent L.
|
|
|
|
6 |
p. 673-683
|
artikel
|
| 29 |
Biosimilars in the EU: Nonclinical and Early Clinical Development
|
Voisin, Emmanuelle
|
|
|
|
6 |
p. 741-743
|
artikel
|
| 30 |
Certification for the Medical Science Liaison: An Idea Whose Time Has Come—or Not
|
Chin, Jane
|
|
|
|
6 |
p. 819-823
|
artikel
|
| 31 |
Clinically Important Effects in New Drug Development
|
Togo, Kanae
|
|
|
|
6 |
p. 805-810
|
artikel
|
| 32 |
Clinical Trials: Rethinking How We Ensure Quality
|
Landray, Martin J.
|
|
2012
|
|
6 |
p. 657-660
|
artikel
|
| 33 |
Clinical Trials: Rethinking How We Ensure Quality
|
Landray, Martin J.
|
|
|
|
6 |
p. 657-660
|
artikel
|
| 34 |
Commentary: The Real-world Convergence of Comparative Effectiveness Research and Risk-Beneft Assessment
|
Doyle, John J.
|
|
|
|
6 |
p. 691-696
|
artikel
|
| 35 |
Confirm and Explore: A Stepwise Approach to Clinical Study Designs
|
Ting, Naitee
|
|
|
|
6 |
p. 545-554
|
artikel
|
| 36 |
Content Analysis of Off-label Drug Use: Reporting Print Media Coverage
|
Patel, Dipen A.
|
|
|
|
6 |
p. 787-796
|
artikel
|
| 37 |
Content Analysis of the Videos Featuring Prescription Drug Advertisements in Social Media: YouTube
|
Yang, Mo
|
|
2012
|
|
6 |
p. 715-722
|
artikel
|
| 38 |
Content Analysis of the Videos Featuring Prescription Drug Advertisements in Social Media: YouTube
|
Yang, Mo
|
|
|
|
6 |
p. 715-722
|
artikel
|
| 39 |
Data Monitoring in Clinical Trials Using Prediction
|
Evans, Scott R.
|
|
|
|
6 |
p. 733-742
|
artikel
|
| 40 |
Development of a Web-Based Compliance Metrics Reporting Dashboard (CMR©) for Medical Information Inquiries
|
Fuentes, Robert J.
|
|
2012
|
|
6 |
p. 729-735
|
artikel
|
| 41 |
Development of a Web-Based Compliance Metrics Reporting Dashboard (CMR©) for Medical Information Inquiries
|
Fuentes, Robert J.
|
|
|
|
6 |
p. 729-735
|
artikel
|
| 42 |
DIA/NORD 2012 US Conference on Rare Diseases and Orphan Products: Poster Abstracts
|
|
|
2012
|
|
6 |
p. 748-758
|
artikel
|
| 43 |
DIA/NORD 2012 US Conference on Rare Diseases and Orphan Products: Poster Abstracts
|
|
|
|
|
6 |
p. 748-758
|
artikel
|
| 44 |
Dispensed Medications: Labeling Patterns and Patient Knowledge at a Tertiary Care University Hospital in Southwest Ethiopia
|
Yabite, Hawi
|
|
2012
|
|
6 |
p. 688-693
|
artikel
|
| 45 |
Dispensed Medications: Labeling Patterns and Patient Knowledge at a Tertiary Care University Hospital in Southwest Ethiopia
|
Yabite, Hawi
|
|
|
|
6 |
p. 688-693
|
artikel
|
| 46 |
Editor’s Commentary
|
Turner, J. Rick
|
|
2012
|
|
6 |
p. 643-644
|
artikel
|
| 47 |
Editor’s Commentary
|
Turner, J. Rick
|
|
|
|
6 |
p. 643-644
|
artikel
|
| 48 |
Editor’s Commentary: A Time for Refection and Anticipation
|
Turner, J. Rick
|
|
|
|
6 |
p. 687-689
|
artikel
|
| 49 |
Enhancing Control of the Medication Supply Chain in Clinical Trials Managed by Interactive Voice Response Systems
|
Waters, Sarah
|
|
|
|
6 |
p. 727-740
|
artikel
|
| 50 |
Evaluating REMS Tools: Issues in Survey Design
|
Morris, Louis A.
|
|
|
|
6 |
p. 735-747
|
artikel
|
| 51 |
Evaluating the Content of Advertisements for Dietary Supplements in Malaysian Women’s Magazines
|
Hassali, Mohamed Azmi
|
|
2012
|
|
6 |
p. 723-728
|
artikel
|
| 52 |
Evaluating the Content of Advertisements for Dietary Supplements in Malaysian Women’s Magazines
|
Hassali, Mohamed Azmi
|
|
|
|
6 |
p. 723-728
|
artikel
|
| 53 |
Evaluation of Drug Adverse Event Intake and Reporting in a Medical Information Service
|
Allen, Pamela D.
|
|
|
|
6 |
p. 767-773
|
artikel
|
| 54 |
Failure to Communicate: Medication Guide or Memory?
|
Morris, Louis A.
|
|
|
|
6 |
p. 775-786
|
artikel
|
| 55 |
Fewer Drugs, Shorter Lives, Less Prosperity: The Impact of Comparative Effectiveness Research on Health and Wealth
|
Vernon, John
|
|
|
|
6 |
p. 699-703
|
artikel
|
| 56 |
Globalization Facilitates Pediatric Drug Development in the 21 st Century
|
Dunne, Julia
|
|
|
|
6 |
p. 757-765
|
artikel
|
| 57 |
Guest Editor’s Note: 20th Anniversary Special Section on Medical Communications
|
Vermeulen, Rebecca
|
|
|
|
6 |
p. 635-636
|
artikel
|
| 58 |
Guide to Paediatric Clinical Research
|
Schaad, Urs B.
|
|
|
|
6 |
p. 791
|
artikel
|
| 59 |
Heat Map Displays for Data From Human Abuse Potential Crossover Studies
|
Chen, Ling
|
|
2012
|
|
6 |
p. 701-707
|
artikel
|
| 60 |
Heat Map Displays for Data From Human Abuse Potential Crossover Studies
|
Chen, Ling
|
|
|
|
6 |
p. 701-707
|
artikel
|
| 61 |
Historical Perspective of Technologies Used in Medical Communications, Past, Present, and Future
|
Fierro, Lesley
|
|
|
|
6 |
p. 705-712
|
artikel
|
| 62 |
How Biased Are Indirect Comparisons, Particularly When Comparisons Are Made Over Time in Controlled Trials?
|
Julious, Steven A.
|
|
|
|
6 |
p. 625-633
|
artikel
|
| 63 |
Identifying Safety Indicators of New Drug Safety Monitoring Programme (SMP) in Thailand
|
Amrumpai, Yaowalak
|
|
|
|
6 |
p. 769-777
|
artikel
|
| 64 |
Interim Analysis: What Regulatory Affairs Professionals Need to Know
|
Coutant, David
|
|
|
|
6 |
p. 703-712
|
artikel
|
| 65 |
Interpretation of a Self-Esteem Subscale for Erectile Dysfunction by Cumulative Logit Model
|
Cappelleri, Joseph C.
|
|
|
|
6 |
p. 723-732
|
artikel
|
| 66 |
Interventions Assessment of Prescription Automatic Screening System in Chinese Hospitals: A Systematic Review
|
Yang, Chunyan
|
|
2012
|
|
6 |
p. 669-676
|
artikel
|
| 67 |
Interventions Assessment of Prescription Automatic Screening System in Chinese Hospitals: A Systematic Review
|
Yang, Chunyan
|
|
|
|
6 |
p. 669-676
|
artikel
|
| 68 |
Legal Requirements for Drug Information Resources Maintained by Pharmacies
|
Clauson, Kevin A.
|
|
|
|
6 |
p. 569-582
|
artikel
|
| 69 |
Letter to the Editor
|
Zhang, Joanne
|
|
|
|
6 |
p. 713-715
|
artikel
|
| 70 |
Medical Information Services in the Age of Social Media and New Customer Channels
|
Bordoloi, Poonam
|
|
|
|
6 |
p. 811-818
|
artikel
|
| 71 |
Medical Information Support of the Sales Force: An External and Internal Assessment
|
Advani, Ashish
|
|
|
|
6 |
p. 685-691
|
artikel
|
| 72 |
Online Signal Management: A Systems-Based Approach That Delivers New Analytical Capabilities and Operational Efficiency to the Practice of Pharmacovigilance
|
Almenoff, June S.
|
|
|
|
6 |
p. 779-789
|
artikel
|
| 73 |
Opening the Black Box of Pharmaceutical Patent Value: An Empirical Analysis
|
Hu, Yuanjia
|
|
|
|
6 |
p. 561-568
|
artikel
|
| 74 |
Optimal Allocation of Prognostic Factors in Randomized Preclinical Animal Studies
|
Su, Zheng
|
|
|
|
6 |
p. 725-729
|
artikel
|
| 75 |
Optimal Failure-Success Response-Adaptive Designs for Binary Responses
|
Zhang, Lanju
|
|
|
|
6 |
p. 709-718
|
artikel
|
| 76 |
Planning and Executing Response-Adaptive Learn-Phase Clinical Trials: 2. Case Studies
|
Fardipour, Parvin
|
|
|
|
6 |
p. 725-734
|
artikel
|
| 77 |
Planning and Executing Response-Adaptive Learn-Phase Clinical Trials: 1. The Process
|
Fardipour, Parvin
|
|
|
|
6 |
p. 713-723
|
artikel
|
| 78 |
Platelet Aggregation Quality Control in a Multicenter, Phase 2 Clinical Trial
|
McRedmond, James
|
|
|
|
6 |
p. 731-740
|
artikel
|
| 79 |
Practical Application of the Continual Reassessment Method to a Phase I Dose-Finding Trial in Advanced Breast Cancer
|
Morita, Satoshi
|
|
|
|
6 |
p. 691-700
|
artikel
|
| 80 |
Preparing for a Safety Inspection
|
Jolley, Steve
|
|
|
|
6 |
p. 705-711
|
artikel
|
| 81 |
Product Launch and the Strategies, Processes, and Operations of Medical Affairs to Support Start-Up Companies
|
Evens, Ronald P.
|
|
|
|
6 |
p. 743-759
|
artikel
|
| 82 |
Publishing a Drug Information Bulletin: Experiences From a Developing Country
|
Shankar, P. Ravi
|
|
|
|
6 |
p. 555-559
|
artikel
|
| 83 |
Refinement of the Clinical Scenario Evaluation Framework for Assessment of Competing Development Strategies with an Application to Multiple Sclerosis
|
Friede, Tim
|
|
|
|
6 |
p. 713-718
|
artikel
|
| 84 |
Results of a Qualitative Market Research Study Evaluating the Quality of Medical Letters
|
Fett, Radeguade
|
|
|
|
6 |
p. 697-703
|
artikel
|
| 85 |
Review of Clinical Trial Design: Bayesian and Frequentist Adaptive Methods
|
Zink, Richard C.
|
|
2012
|
|
6 |
p. 746-747
|
artikel
|
| 86 |
Review of Clinical Trial Design: Bayesian and Frequentist Adaptive Methods
|
Zink, Richard C.
|
|
|
|
6 |
p. 746-747
|
artikel
|
| 87 |
Review of From Alzheimer’s to Zebrafish: Eclectic Science and Regulatory Stories
|
Tabor, Edward
|
|
2012
|
|
6 |
p. 744-744
|
artikel
|
| 88 |
Review of From Alzheimer’s to Zebrafish: Eclectic Science and Regulatory Stories
|
Tabor, Edward
|
|
|
|
6 |
p. 744
|
artikel
|
| 89 |
Review of: Fundamentals of US Regulatory Affairs, 7th ed.
|
Tabor, Edward
|
|
|
|
6 |
p. 825-826
|
artikel
|
| 90 |
Review of Good Clinical Practice: A Question & Answer Reference Guide
|
Tabor, Edward
|
|
2012
|
|
6 |
p. 744-745
|
artikel
|
| 91 |
Review of Good Clinical Practice: A Question & Answer Reference Guide
|
Tabor, Edward
|
|
|
|
6 |
p. 744-745
|
artikel
|
| 92 |
Review of IND Submissions: A Primer
|
Tabor, Edward
|
|
2012
|
|
6 |
p. 746-746
|
artikel
|
| 93 |
Review of IND Submissions: A Primer
|
Tabor, Edward
|
|
|
|
6 |
p. 746
|
artikel
|
| 94 |
Review of Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional
|
Tabor, Edward
|
|
2012
|
|
6 |
p. 745-746
|
artikel
|
| 95 |
Review of Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional
|
Tabor, Edward
|
|
|
|
6 |
p. 745-746
|
artikel
|
| 96 |
Risk-Based Source Data Verification Approaches: Pros and Cons
|
Tantsyura, Vadim
|
|
|
|
6 |
p. 745-756
|
artikel
|
| 97 |
Statistical Test for Ordered Categorical Data in Clinical Trials
|
Chow, Shein-Chung
|
|
|
|
6 |
p. 617-624
|
artikel
|
| 98 |
Subject Numbers and Placebo Outcome Variability in Clinical Trials of New CNS Medications
|
Ridgway, Derry
|
|
|
|
6 |
p. 701-708
|
artikel
|
| 99 |
Surveying Medical Information Across Europe: The Present and the Future
|
Leigbton, Sharon
|
|
|
|
6 |
p. 637-654
|
artikel
|
| 100 |
Surveys of Medical Liaison Practices Across the Pharmaceutical Industry: A Review
|
Bass, J. Lynn
|
|
|
|
6 |
p. 685-695
|
artikel
|
| 101 |
Ten-year Experience of the Evaluation of Ethnic Sensitivity Data
|
Hsiao, Chia-Ling
|
|
|
|
6 |
p. 717-724
|
artikel
|
| 102 |
The Changing Roles of Medical Communications Professionals: Evolution of the Core Curriculum
|
Codogan, Alicia Alexander
|
|
|
|
6 |
p. 673-684
|
artikel
|
| 103 |
The Current Situation of Oncology Drug Lag in Japan and Strategic Approaches for Pharmaceutical Companies
|
Hashimoto, Junichi
|
|
|
|
6 |
p. 757-765
|
artikel
|
| 104 |
The Drug Information Center at the Manipal Teaching Hospital—Going beyond Drug Information
|
Shankar, P. Ravi
|
|
|
|
6 |
p. 761-768
|
artikel
|
| 105 |
The Effect of Feedback With Photo-Novella Information Sheets on Subjects’ Understanding in Informed Consent for Research
|
Jeong, Ihn Sook
|
|
2012
|
|
6 |
p. 661-668
|
artikel
|
| 106 |
The Effect of Feedback With Photo-Novella Information Sheets on Subjects’ Understanding in Informed Consent for Research
|
Jeong, Ihn Sook
|
|
|
|
6 |
p. 661-668
|
artikel
|
| 107 |
The Future of Allergen-Specific Immunotherapy
|
Jutel, Marek
|
|
2012
|
|
6 |
p. 683-687
|
artikel
|
| 108 |
The Future of Allergen-Specific Immunotherapy
|
Jutel, Marek
|
|
|
|
6 |
p. 683-687
|
artikel
|
| 109 |
The Importance of Medical Innovation in an Investigator’s Decision to Take Part in Clinical Trials
|
Gloss, Harold E.
|
|
|
|
6 |
p. 537-543
|
artikel
|
| 110 |
Use of Proprietary Names by Prescribers for Discontinued Brand Drug Products With Existing Generic Equivalents
|
Tu, Chi-Ming
|
|
2012
|
|
6 |
p. 677-682
|
artikel
|
| 111 |
Use of Proprietary Names by Prescribers for Discontinued Brand Drug Products With Existing Generic Equivalents
|
Tu, Chi-Ming
|
|
|
|
6 |
p. 677-682
|
artikel
|
| 112 |
Validation of Decision-enabling Tools: Showing That the Model Is Useful
|
Sjögren, Niclas
|
|
|
|
6 |
p. 759-765
|
artikel
|
Tijdschrift beschrijving